National Comprehensive Cancer Network

Interactive CME


Educational Events & Programs

NCCN 13th Annual Congress: Hematologic Malignancies™


DATES > Friday, September 21 – Saturday, September 22, 2018
            LEARN MORE>

LOCATION > New York Marriott Marquis ǀ New York, New York

View timed agenda and topics here.


 


You may also be interested in this pre-Congress program:
NCCN Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™  
LEARN MORE>
Friday, September 21, 2018 | 2:00 – 5:15 PM 
New York Marriott Marquis • New York, New York

Overview

World-renowned experts in the management of Hematologic Malignancies will present the latest treatment advances, updates to the standard of care as recommended in the NCCN Guidelines®, and unique and challenging patient cases.

Co-chaired by Ranjana H. Advani, MD, Stanford Cancer Institute, and Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center, this one-and-a-half day program will feature presentations and panel discussions on patient cases highlighting the treatment options and supportive care for a variety of hematological malignancies including leukemias, lymphomas, myeloproliferative neoplasms and plasma cell neoplasms. The Keynote Session: CAR T-Cell Therapy will include an overview/introduction and focus on lymphomas and leukemia including management of toxicities.

HEM 2018


Agenda*

View timed agenda and topics here.

Friday, September 21, 2018

4:30 – 6:00 PM

Registration, Exhibits, and Refreshments

6:00 – 8:25 PM

Educational Sessions

 

Saturday, September 22, 2018

6:30 AM

Registration Opens

7:00 – 8:00 AM

Registration, Exhibits, and Breakfast

8:00 AM – 5:00 PM

Educational Sessions
(Lunch will be provided to all congress attendees.)

*This agenda is subject to change. Faculty will be updated as confirmed.


Intended Audience
This congress is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.

Accreditation
This program has been approved for AMA PRA Category 1 Credit™ and ABIM and ABMS MOC points for physicians and will award contact hours for nurses, pharmacists, and other health care professionals. Learn more.

Fees
Early Bird Registration expired Friday, August 10, 2018. Learn more.

Special discounts are available for staff employed at NCCN Member Institutions. Complimentary registration is available for Residents, Fellows, and Junior Faculty at NCCN Member Institutions. A list of NCCN Member Institutions is available here. Please contact Liz Rieder, Senior Registration Manager, at conferences@nccn.org to learn how to apply this discount.

Supporters
This activity is supported by educational grants from: Astellas; AstraZeneca; Celgene Corporation; Jazz Pharmaceuticals, Inc.; MEI Pharma; Novartis; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Pfizer; Sanofi Genzyme; and Takeda Oncology. This activity is supported by independent educational grants from AbbVie and Incyte. This activity is supported by educational funding provided by Amgen. This activity is supported by an unrestricted educational grant from Gilead Sciences, Medical Affairs. 
This list of supporters was last updated on September 17, 2018.

Supporter Opportunities
Organizations who are interested in supporting NCCN CE programs are encouraged to contact Lisa Perfidio. View a list of supporters here.

Sponsorship and exhibit opportunities are available. For more information, contact Jennifer Tredwell.


EXHIBITOR INFORMATION

NCCN 13th Annual Congress: Hematologic Malignancies™ – Exhibition Guide

NCCN 13th Annual Congress: Hematologic Malignancies™ – Exhibitor Floor Plan

NCCN 13th Annual Congress: Hematologic Malignancies™ – Show Services Kit


Blackout Times
NCCN requests that any sponsor, exhibitor, or non-sponsor respect the intent of this event. Therefore, any non-NCCN events, whether on the event property or off-premises but within the city limits, that might potentially draw participants from registered attendees, faculty, or speakers of the NCCN 13th Annual Congress: Hematologic Malignancies™ are prohibited.

NCCN appreciates the understanding and cooperation of all entities involved. For any questions regarding this policy, please e-mail: exhibits@nccn.org

The blackout times for this event are Friday, September 21, 2018 beginning at 1:00 PM to Saturday, September 22, 2018 ending at 5:00 PM. Thank you.


FUTURE ANNUAL CONGRESS DATES

  • September 27 – 28, 2019
    NCCN 2019 Annual Congress: Hematologic Malignancies™
    San Francisco, CA

Please check back often for the most up-to-date information. Please contact 866.788.NCCN (6226) or send an e-mail if you have additional questions.